Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
Publishing timestamp: 2024-02-13 12:21:57
Summary
The article discusses a federal judge dismissing a lawsuit brought by major pharmaceutical industry lobbying group PhRMA, the Global Colon Cancer Association, and the National Infusion Center Association. The lawsuit challenged Medicare's new powers to negotiate prices for prescription medicines. The judge's decision is seen as an early win for the Biden administration, but the legal battle over the policy is not over and could potentially reach the Supreme Court. The article also mentions that other major companies, including J&J, Merck, and Bristol Myers Squibb, have filed separate lawsuits challenging the constitutionality of the price talks.
Sentiment: NEUTRAL
Tickers: BMY, MRK, LLY, PFE, JNJ,
Keywords: biotechnology, breaking news: politics, business news, health care industry, pharmaceuticals, politics, social issues, business, johnson & johnson, bristol-myers squibb co, merck & co inc, biotech and pharmaceuticals, pfizer inc, eli lilly and co,
Source: https://www.cnbc.com/2024/02/13/medicare-drug-price-negotiations-judge-tosses-phrma-lawsuit.html